Amna Umer1, Sean Loudin2, Stefan Maxwell3, Christa Lilly4, Meagan E Stabler5, Lesley Cottrell6, Candice Hamilton6, Janine Breyel7, Christina Mullins8, Collin John6. 1. Department of Pediatrics, School of Medicine, West Virginia University, Morgantown, WV, 26506, USA. amumer@hsc.wvu.edu. 2. Department of Pediatrics, School of Medicine, Marshall University, Huntington, WV, 25701, USA. 3. PEDIATRIX Medical Group, Department of Pediatrics, WV School of Medicine (Charleston division), Women and Children's Hospital, Charleston, SC, USA. 4. Department of Biostatistics, School of Public Health, West Virginia University, Morgantown, WV, 26506, USA. 5. Department of Epidemiology, The Geisel School of Medicine at Dartmouth, Hanover, NH, 03755, USA. 6. Department of Pediatrics, School of Medicine, West Virginia University, Morgantown, WV, 26506, USA. 7. West Virginia Perinatal Partnership, Department of Obstetrics and Gynecology, School of Medicine, West Virginia University, Morgantown, WV, 26506, USA. 8. Office of Maternal, Child and Family Health, West Virginia Department of Health and Human Resources, Charleston, WV, USA.
Abstract
BACKGROUND: Neonatal abstinence syndrome (NAS) is one of the consequences at birth affecting the newborn after discontinuation of prenatal drug exposure to mainly opioids. The objective of this study was to determine the extent of the problem in the state of West Virginia (WV) using a real-time statewide surveillance system. METHODS: Project WATCH is a surveillance tool that since 1998 collects data on all infants born in the state of WV. NAS surveillance item was added to the tool in October 2016. This study examined all births (N = 23,667) in WV from October to December 2017. The data from six WV birthing facilities were audited for 1 month to evaluate how well this tool was capturing NAS data using κ-statistics. RESULTS: The 2017 annual incidence rate of NAS was 51.3 per 1000 live births per year for all births and 50.6 per 1000 live births per year for WV residents only. The κ-coefficient between the hospital medical records and Project WATCH data was 0.74 (95% confidence interval: 0.66-0.82) for NAS. CONCLUSION: The study provides justification to develop effective systems of care for the mother-infant dyad affected by substance use, especially targeting pregnant women in rural communities.
BACKGROUND:Neonatal abstinence syndrome (NAS) is one of the consequences at birth affecting the newborn after discontinuation of prenatal drug exposure to mainly opioids. The objective of this study was to determine the extent of the problem in the state of West Virginia (WV) using a real-time statewide surveillance system. METHODS: Project WATCH is a surveillance tool that since 1998 collects data on all infants born in the state of WV. NAS surveillance item was added to the tool in October 2016. This study examined all births (N = 23,667) in WV from October to December 2017. The data from six WV birthing facilities were audited for 1 month to evaluate how well this tool was capturing NAS data using κ-statistics. RESULTS: The 2017 annual incidence rate of NAS was 51.3 per 1000 live births per year for all births and 50.6 per 1000 live births per year for WV residents only. The κ-coefficient between the hospital medical records and Project WATCH data was 0.74 (95% confidence interval: 0.66-0.82) for NAS. CONCLUSION: The study provides justification to develop effective systems of care for the mother-infant dyad affected by substance use, especially targeting pregnant women in rural communities.
Authors: Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori Journal: Drug Saf Date: 2016-10 Impact factor: 5.606
Authors: G Klinger; D Frankenthal; P Merlob; G Diamond; L Sirota; R Levinson-Castiel; N Linder; B Stahl; D Inbar Journal: J Perinatol Date: 2011-02-10 Impact factor: 2.521
Authors: Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis Journal: JAMA Date: 2012-04-30 Impact factor: 56.272
Authors: Jean Y Ko; Stephen W Patrick; Van T Tong; Roshni Patel; Jennifer N Lind; Wanda D Barfield Journal: MMWR Morb Mortal Wkly Rep Date: 2016-08-12 Impact factor: 17.586
Authors: Michael D Warren; Angela M Miller; Julie Traylor; Audrey Bauer; Stephen W Patrick Journal: MMWR Morb Mortal Wkly Rep Date: 2015-02-13 Impact factor: 17.586
Authors: Krista F Huybrechts; Brian T Bateman; Rishi J Desai; Sonia Hernandez-Diaz; Kathryn Rough; Helen Mogun; Leslie S Kerzner; Jonathan M Davis; Megan Stover; Devan Bartels; Jennifer Cottral; Elisabetta Patorno Journal: BMJ Date: 2017-08-02
Authors: Julia Brennan; Caleb Wiedeman; John R Dunn; William Schaffner; Timothy F Jones Journal: Public Health Rep Date: 2019-08-07 Impact factor: 2.792